Professor
University of Alabama at Birmingham
Birmingam, Alabama, United States
Extracorporeal therapies for Intoxication
Friday, May 3, 2024
12:30 PM – 1:00 PM ET
Disclosure(s): Abbott (Ongoing) (Products/Services: Consultant); Baxter (Ongoing) (Products/Services: Consultant); Bioporto (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); leadiant (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Nuwellis (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Seastar (Ongoing) (Products/Services: Consultant); Zorro-Flow Inc. (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Saturday, May 4, 2024
8:00 AM – 9:30 AM ET
Disclosure(s): Abbott (Ongoing) (Products/Services: Consultant); Baxter (Ongoing) (Products/Services: Consultant); Bioporto (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); leadiant (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Nuwellis (Ongoing) (Products/Services: Consultant, Research Support including clinical trials & the principal or named investigator); Seastar (Ongoing) (Products/Services: Consultant); Zorro-Flow Inc. (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)